chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 69.0
Sex: F
Vaccine: FLUA3
Symptoms: Eye operation, Hypoaesthesia, Injection site pain, Limb operation, Pain
Clinical narrative: This spontaneous case, reported by healthcare professional (other) to VAERS and initially retrieved on 30-Mar-2018 by Seqirus from VAERS (VAERS ID: 726230), concerns a 69-year-old, elderly, female patient. The patient's current conditions included thyroid disorder, hypothyroidism and allergies (unspecified) and right-side breast cancer (since an unspecified date). The patient's concomitant medications included ciclopirox olamine lotion, NEILMED, levocetirizine; XYZAL, melatonin, PATANASE, epinephrine, glucocorticoid, fluticasone propionate, ATROVENT, PATADAY, Triamcinolone Acetonide, APEXICON and Tacroli. On 08-Sep-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number: 178323 and expiry date: not reported). On the same day, after the vaccination, the patient experienced persistent arm pain, muscle ache in area of injection, which worsened with exercise, flexing arm and during eye surgery (on 01-Nov-2017). It was reported that, the patient's left arm became extremely achy, hand was ice cold and numb. On 10-Nov-2017, the patient reported surgery complications (unspecified), pain, ache in physician office. Blood pressure cuff put of left arm (due to right side breast cancer). On 15-Nov-2017, the patient went for second arm surgery. At the time of this report, the patient had not yet recovered from the events. The reporter assessed the events as non-serious.
Age: 69.0
Sex: F
Vaccine: FLUA3
Symptoms: Pain in extremity, Peripheral coldness, Procedural complication
Clinical narrative: This spontaneous case, reported by healthcare professional (other) to VAERS and initially retrieved on 30-Mar-2018 by Seqirus from VAERS (VAERS ID: 726230), concerns a 69-year-old, elderly, female patient. The patient's current conditions included thyroid disorder, hypothyroidism and allergies (unspecified) and right-side breast cancer (since an unspecified date). The patient's concomitant medications included ciclopirox olamine lotion, NEILMED, levocetirizine; XYZAL, melatonin, PATANASE, epinephrine, glucocorticoid, fluticasone propionate, ATROVENT, PATADAY, Triamcinolone Acetonide, APEXICON and Tacroli. On 08-Sep-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number: 178323 and expiry date: not reported). On the same day, after the vaccination, the patient experienced persistent arm pain, muscle ache in area of injection, which worsened with exercise, flexing arm and during eye surgery (on 01-Nov-2017). It was reported that, the patient's left arm became extremely achy, hand was ice cold and numb. On 10-Nov-2017, the patient reported surgery complications (unspecified), pain, ache in physician office. Blood pressure cuff put of left arm (due to right side breast cancer). On 15-Nov-2017, the patient went for second arm surgery. At the time of this report, the patient had not yet recovered from the events. The reporter assessed the events as non-serious.
Age: 76.0
Sex: F
Vaccine: FLUA3, PPV
Symptoms: Erythema, Peripheral swelling
Clinical narrative: This spontaneous case, reported by other health care professional to VAERS and initially retrieved on 30-Mar-2018 by Seqirus from VAERS (VAERS ID: 726234), concerns a 76-year-old, elderly, female patient. The patient's current condition included diabetes, hypertension and osteogenesis (since an unspecified date). The patient had no known allergies. The concomitant medications included sertraline, simvastatin, lisinopril and glimepiride for an unknown indication (since an unspecified date). On 17-Oct-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml (1 as report), route of administration: intramuscular, anatomical location: left arm, batch number: 178503 and expiry date: not reported) and on the same day, the patient was administered with non-company suspect product, PNEUMOVAX (route of administration: intramuscular, anatomical location: right arm, batch number: N020502, dose and expiry date: not reported). On 20-Oct-2017, after 3 days of vaccination, the patient's right arm was red and swelled from down the elbow to hand. The arm did not swell from above the elbow. On an unspecified date, the patient went to emergency room and treated with doxycycline hyclate (100 mg, once daily for 10 days). It was reported that, the patient had recovered well. At the time of the report, the patient had recovered from the events (erythema and peripheral swelling). The reporter assessed the case as non-serious.
Age: 68.0
Sex: F
Vaccine: FLUA3, PPV
Symptoms: Injected limb mobility decreased, Neck pain, Pain in extremity, Peripheral swelling
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 30-Mar-2018 by Seqirus from VAERS (VAERS ID: 726261), concerns a 68-year-old elderly female patient. The patient's current condition included multiple sclerosis and no allergies were reported. On 10-Nov-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number: 179502) and PNEUMOVAX (dose: 1 as reported, route of administration: intramuscular, anatomical location: right arm, batch number: N019348 as reported). On the same day, after vaccination, the patient developed slightly swollen arm which could not be lifted and also had pain which radiated up to neck and down the arm. No laboratory investigations were performed. The outcome of the events was unknown. The reporter assessed this case as non-serious.
Sex: M
Vaccine: FLUA3
Symptoms: Injection site erythema, Injection site rash
Clinical narrative: This spontaneous case, reported by health care professional (other) to VAERS and initially retrieved on 30-Mar-2018 by Seqirus from VAERS (VAERS ID: 726274), concerns 88-year-old elderly male patient. On 03-Nov-2017, the patient was administered with FLUAD (TIV) (dose: 0.5ml, route of administration: intramuscular, anatomical location: left arm, batch number: 178602, expiry date: not reported). On 06-Nov-2017, 3 days after vaccination, the patient experienced red circle and semi rash on the site of injection. The patient had no pain and itchiness, and stated that, he applied hydrocortisone cream prior to consult with the RPH. It was reported that, the red spots had decreased. The patient was recovered from the events. The reporter assessed this case as non-serious.
Age: 65.0
Sex: M
Vaccine: FLUA3
Symptoms: Arthralgia, Chills, Fatigue, Feeling abnormal, Immediate post-injection reaction
Clinical narrative: This spontaneous case, reported by other non-healthcare professional (consumer) to VAERS and initially retrieved on 30-Mar-2018 by Seqirus from VAERS (VAERS ID: 726282), concerns a 65-year-old, elderly, male patient. The patient's current condition included diabetes mellitus (since an unspecified date). The patient had been allergic to penicillin. The patient's concomitant medications were not reported. On 01-Nov-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml, route of administration: injection (reported as SYR), anatomical: right arm, batch number and expiry date: not reported). On the same day, immediately after the vaccination, when patient stood up, she experienced pain in her leg joints and pain quickly resolved on walking. Within about one hour of vaccination, the patient experienced chills all over his body. It was reported that,chills were unbearable and developed a fever of 103.4 (in evening and night). The fever and adverse feeling lasted for about 24 hours. After two days, the patient was fine but had some fatigue. On an unspecified date, the patient had recovered from the all the events except the event (lingering fatigue) which was not recovered. The reporter assessed the events as non-serious. Non-significant case correction received with the IRD 30-Mar-2018: The sentence in the narrative was corrected from (when patient stand up) to (when patient stood up).
Age: 65.0
Sex: M
Vaccine: FLUA3
Symptoms: Pain in extremity, Pyrexia
Clinical narrative: This spontaneous case, reported by other non-healthcare professional (consumer) to VAERS and initially retrieved on 30-Mar-2018 by Seqirus from VAERS (VAERS ID: 726282), concerns a 65-year-old, elderly, male patient. The patient's current condition included diabetes mellitus (since an unspecified date). The patient had been allergic to penicillin. The patient's concomitant medications were not reported. On 01-Nov-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml, route of administration: injection (reported as SYR), anatomical: right arm, batch number and expiry date: not reported). On the same day, immediately after the vaccination, when patient stood up, she experienced pain in her leg joints and pain quickly resolved on walking. Within about one hour of vaccination, the patient experienced chills all over his body. It was reported that,chills were unbearable and developed a fever of 103.4 (in evening and night). The fever and adverse feeling lasted for about 24 hours. After two days, the patient was fine but had some fatigue. On an unspecified date, the patient had recovered from the all the events except the event (lingering fatigue) which was not recovered. The reporter assessed the events as non-serious. Non-significant case correction received with the IRD 30-Mar-2018: The sentence in the narrative was corrected from (when patient stand up) to (when patient stood up).
Age: 70.0
Sex: F
Vaccine: FLUA3
Symptoms: Haemorrhage, Injection site erythema, Injection site swelling, Myalgia, Pain
Clinical narrative: This spontaneous case, reported by other health care professional to VAERS and initially retrieved on 30-Mar-2018 by Seqirus from VAERS (VAERS ID: 726283), concerns a 70-year-old, elderly, female patient. The patient's procedure included hormone replacement for thyroid (on an unspecified date). The current condition included diverticulitis (since an unspecified date in Jan-2017) and hay fever (since an unspecified date). The patient was allergic to codeine, hydrocodone and ether (since an unspecified date). The concomitant medication included probiotics (since an unspecified date). On 01-Oct-2017, the patient was administered with FLUAD (dose: 0.5 ml (1 as reported), route of administration: intramuscular, anatomical location: right arm, batch number and expiry date: not reported). On 30-Oct-2017, after 29 days of the vaccination, the patient experienced scab bleed (bled as reported) and a little pain at deltoid. On 11-Nov-2017, the patient again experienced bleed from the bumped scab which was more than from first time. On 12-Nov-2017, after 1 month 11 days of vaccination, the patient still experienced pain, the area around the injection site was became red and a little raised. The patient had no lab data (as reported). At the time of the report, the patient had not recovered from the events (bleeding, pain in extremity, muscle pain, injection site pain, injection site swelling and injection site redness). The reporter assessed the case as non-serious. Significant case correction received 30-Mar-2018: As determined causality of the events (bleeding, pain in extremity, muscle pain, injection site pain, injection site swelling, injection site redness) was changed from unassessable to related and case comment was corrected accordingly.
Age: 70.0
Sex: F
Vaccine: FLUA3
Symptoms: Scab
Clinical narrative: This spontaneous case, reported by other health care professional to VAERS and initially retrieved on 30-Mar-2018 by Seqirus from VAERS (VAERS ID: 726283), concerns a 70-year-old, elderly, female patient. The patient's procedure included hormone replacement for thyroid (on an unspecified date). The current condition included diverticulitis (since an unspecified date in Jan-2017) and hay fever (since an unspecified date). The patient was allergic to codeine, hydrocodone and ether (since an unspecified date). The concomitant medication included probiotics (since an unspecified date). On 01-Oct-2017, the patient was administered with FLUAD (dose: 0.5 ml (1 as reported), route of administration: intramuscular, anatomical location: right arm, batch number and expiry date: not reported). On 30-Oct-2017, after 29 days of the vaccination, the patient experienced scab bleed (bled as reported) and a little pain at deltoid. On 11-Nov-2017, the patient again experienced bleed from the bumped scab which was more than from first time. On 12-Nov-2017, after 1 month 11 days of vaccination, the patient still experienced pain, the area around the injection site was became red and a little raised. The patient had no lab data (as reported). At the time of the report, the patient had not recovered from the events (bleeding, pain in extremity, muscle pain, injection site pain, injection site swelling and injection site redness). The reporter assessed the case as non-serious. Significant case correction received 30-Mar-2018: As determined causality of the events (bleeding, pain in extremity, muscle pain, injection site pain, injection site swelling, injection site redness) was changed from unassessable to related and case comment was corrected accordingly.
Age: 70.0
Sex: F
Vaccine: FLUA3, PPV
Symptoms: Injection site erythema, Injection site pruritus, Injection site swelling
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 30-Mar-2018 by Seqirus from VAERS (VAERS ID: 726349), concerning a 70-year-old, elderly female patient. The patient's current conditions included: hypertension and hyperthyroidism since an unspecified ate. Concomitant medications included HYZAAR, SYNTHROID and Triamcinolone for an unknown indication. On 10-Nov-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml (reported as 1 dose), route of administration: intramuscular, anatomical location: left arm, batch number: 179523, expiry date: not reported). On the same day, the patient was administered with non-company suspect drug, PNEUMOVAX (dose: 1 DF, route of administration: intramuscular, anatomical location: left arm, batch number: N010105, expiry date: not reported). It was reported that both the vaccines were given in the left deltoid, but flu vaccine was injected towards front of PNEUMOVAX. On 12-Nov-2017, after 2 days of vaccination, the patient experienced redness, swelling (slightly) and itching at the site where flu vaccine was injected. No lab test was done. At the time of this report, the outcome of the events was unknown. The reporter assessed the case as non-serious.
Age: 75.0
Sex: M
Vaccine: FLUA3
Symptoms: Rash
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 30-Mar-2018 by Seqirus from VAERS (VAERS ID: 726411), concerns a 75-year-old, elderly male patient. The patient had no medical history, current illness, any lab data and concomitant medications. On 04-Nov-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number: 178902, expiry date: not reported). On the same day evening after vaccination, the patient developed rash in the midsection of the body and on both arms. The rash began to fade within 24 hours. The patient consulted a physician and was treated with BENADRYL. On an unspecified date, the patient had recovered from the event. The reporter assessed the case as non-serious.
Age: 66.0
Sex: F
Vaccine: FLUA3
Symptoms: Arthralgia, Pain, Pain in extremity, Sleep disorder
Clinical narrative: This spontaneous case, reported by healthcare professional (other) to VAERS and initially retrieved on 30-Mar-2018 by Seqirus from VAERS (VAERS ID: 726652), concerns a 66-year-old, elderly, female patient. The patient's historical conditions, allergies and concomitant medication were unknown. The patient had no current illness. On 30-Oct-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number: 179302 and expiry date: not reported). On 31-Oct-2017, after 1 day of vaccination, the patient experienced arm soreness for 2 weeks and worsened. The patient also experienced joint pain even on moving her arm. It was reported pain woke up her at night. No lab investigation was done for the events. At the time of this report, the patient had not yet recovered from the events. The reporter assessed the events as non-serious.
Age: 65.0
Sex: F
Vaccine: FLUA3, PPV
Symptoms: Chills, Nausea, Pain in extremity
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 30-Mar-2018 by Seqirus from VAERS (VAERS ID: 726703), concerns a 65-year-old, elderly female patient. The patient's medical history and concomitant medications were not reported. On 24-Oct-2017, the patient was administered with FLUAD (dose: 0.5ml, route of administration: intramuscular, anatomical location: left arm, batch number: 179202, expiry date: not reported) and non-company suspect drug PNEUMOVAX (route of administration: intramuscular, anatomical location: left arm, batch number: N014946, dose, expiry date: not reported). On the same day after vaccination, the patient experienced extremely sore in the arm for three days. Approximately 8 hours after vaccination, the patient experienced nausea and chills. The patient went to bed at 7:15 and woke up feeling better except for soreness in the arm. At the time of this report, the patient was recovering from the events chills and nausea. The outcome of the event pain in extremity was not reported. The reporter assessed the case as non-serious. Non-significant case correction received on 30-Mar-2018: The co-suspect PNEUMOVAX was added in the case comment.
Age: 6.0
Sex: M
Vaccine: FLUA3
Symptoms: Drug administered to patient of inappropriate age, No adverse event
Clinical narrative: This spontaneous case, reported by other health care professional to VAERS and initially retrieved on 30-Mar-2018 by Seqirus from VAERS (VAERS ID: 726911), concerns a 06-year-old, male child. The patient's medical history and the concomitant medications were not reported. On 23-Oct-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number: 178623 and expiry date: not reported) which was recommended to age above 65 years of age (considered as drug administered to patient of inappropriate age). It was reported that, no symptoms or adverse reactions are experienced after this vaccination. The reporter assessed the case as non-serious.
Age: 75.0
Sex: F
Vaccine: FLUA3
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth, Laboratory test normal
Clinical narrative: This spontaneous case, reported by other health care professional to VAERS and initially retrieved on 30-Mar-2018 by Seqirus from VAERS (VAERS ID: 726942), concerns a 75-year-old elderly female patient. The patient had no known allergies and no current illness. However, it was also reported that the patient's concomitant medications included COSOPT, TOPROL, DIOVAN, PROTONIX, ZOCOR and SYNTHROID for an unknown indication. On 13-Nov-2017, the patient received FLUAD (TIV) (dose: 0.5 ml (dose: 1 as reported), route of administration: intramuscular, anatomical location left arm, batch number: 179601 and expiry date: not reported). On 14-Nov-2017, the patient notified the pharmacist that her upper left arm from deltoid to just above the elbow, was red, swollen and warm to touch. The patient was advised to take antihistamine. After 24 hours, the reaction was progressed below the elbow for which she visited emergency room. It was reported that, the laboratory results were negative for any infection. The outcome of the events injection site erythema, injection site swelling, and injection site warmth was not recovered. The reporter assessed this case as non-serious.
Age: 65.0
Sex: F
Vaccine: FLUA3, PNC13
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: This spontaneous case, reported by health care professional (other) to VAERS and initially retrieved on 30-Mar-2018 by Seqirus from VAERS (VAERS ID: 726947), concerns 65-year-old elderly female patient. The patient's current condition included high blood pressure.  The patient's concomitant medications included Lisinopril and Pravastatin. On 07-Nov-2017, the patient was administered with FLUAD (dose: 0.5ml, route of administration: intramuscular, anatomical location: left arm, batch number: 178903 and expiry date: not reported) and was also administered with PREVNAR 13 (dose: 1DF, route of administration: intramuscular, anatomical location: right arm, batch number: S31257, expiry date: not  reported). On the same day of vaccination, the patient experienced redness and swelling on the right upper arm. No laboratory tests were performed. No lab investigations were performed. The outcome of the events reported as unknown. The reporter assessed this case as non-serious.
Sex: M
Vaccine: FLUA3, PPV
Symptoms: Malaise
Clinical narrative: This spontaneous case, reported by a pharmacist to VAERS and initially retrieved on 30-Mar-2018 by Seqirus from VAERS (VAERS ID: 726964), concerns a male patient of an unspecified age. The patient's historical conditions, allergies, current illness and concomitant medications were not reported. On an unspecified date in 2015 (reported as 2 years ago), the patient was administered PNEUMOVAX 23 or PREVNAR 13 (dose, route of administration, anatomical location: unknown, batch number and expiry date: not reported). On an unspecified date, the patient was administered with FLUAD (TIV) (dose: 0.5 ml, route of administration, anatomical location: unknown, batch number and expiry date: not reported) and non-company suspect product PNEUMOVAX 23 (booster dose) (dose, route of administration, anatomical location: unknown, batch number and expiry date: not reported). On an unspecified date, after vaccinations, the patient felt ill. At the time of this report, the outcome of the event was unknown. The reporter assessed the event as non-serious and causality of the event as not related to PNEUMOVAX 23.
Age: 70.0
Sex: F
Vaccine: FLUA3
Symptoms: Arthralgia, Fatigue, Headache, Musculoskeletal chest pain, Musculoskeletal pain
Clinical narrative: This serious spontaneous case, reported by other non-health professional to VAERS and initially retrieved on 30-Mar-2018 by Seqirus from VAERS (VAERS ID: 727004), concerns a 70-year-old elderly female patient. The patient's medical history was not reported. However, patient's concomitant medications included levothyroxine, simvastatin and lisinopril. On 10-Nov-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number: 179303). It was reported that, patient was not ill until the evening of vaccination. On the same day, after vaccination, the patient experienced a sore shoulder as expected followed by fever and pain all over the head, jaw, under the neck and down the neck. The fever got hotter and every rib seemed to hurt, additionally chest muscles and shoulder joints. On 11-Nov-2017 (Saturday), pain progressed in hip joints, knees and somewhat in ankles. Then as the clock ticked past midnight Saturday, fever and pain resolved from feet to head, while pain left the body, however, pain in left jaw increased. On 12-Nov-2017, around 3:00 PM, pain in jaw also decreased. On 13-Nov-2017, the patient felt fine but tired. The patient had recovered from all the events. The reporter assessed the case as non-serious.
Age: 70.0
Sex: F
Vaccine: FLUA3
Symptoms: Neck pain, Pain in jaw, Pyrexia
Clinical narrative: This serious spontaneous case, reported by other non-health professional to VAERS and initially retrieved on 30-Mar-2018 by Seqirus from VAERS (VAERS ID: 727004), concerns a 70-year-old elderly female patient. The patient's medical history was not reported. However, patient's concomitant medications included levothyroxine, simvastatin and lisinopril. On 10-Nov-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number: 179303). It was reported that, patient was not ill until the evening of vaccination. On the same day, after vaccination, the patient experienced a sore shoulder as expected followed by fever and pain all over the head, jaw, under the neck and down the neck. The fever got hotter and every rib seemed to hurt, additionally chest muscles and shoulder joints. On 11-Nov-2017 (Saturday), pain progressed in hip joints, knees and somewhat in ankles. Then as the clock ticked past midnight Saturday, fever and pain resolved from feet to head, while pain left the body, however, pain in left jaw increased. On 12-Nov-2017, around 3:00 PM, pain in jaw also decreased. On 13-Nov-2017, the patient felt fine but tired. The patient had recovered from all the events. The reporter assessed the case as non-serious.
Age: 72.0
Sex: F
Vaccine: FLUA3
Symptoms: Pain in extremity
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 30-Mar-2018 by Seqirus from VAERS (VAERS ID: 727431), concerning a 72-year-old, elderly female patient. The patient's current condition included: diabetes mellitus, hypertension and GERD (Gastro-oesophageal reflux disease). The patient was allergic to morphine. Concomitant medications included: amlodipine, omeprazole, metoprolol, HCTZ, lisinopril and metformin. On 06-Nov-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number: 7046100211, expiry date: not reported). On the same day, after vaccination, the patient's arm was sore. At the time of this report, the patient had not yet recovered from the event. The reporter assessed this case as non-serious.
Age: 77.0
Sex: F
Vaccine: FLUA3
Symptoms: Injection site pain
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 30-Mar-2018 by Seqirus from VAERS (VAERS ID: 727493), concerns a 77-year-old elderly female patient. The patient's medical history was not reported. On 12-Oct-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml (unk as reported), route of administration: intramuscular, anatomical location: left arm, batch number: 179403). On the same day, the patient experienced sore in the vaccinated muscle which persisted (still on 15-Nov-2017). The patient was concerned because the vaccine was administered on 12-Oct-2017. The outcome of all the events was unknown. The reporter assessed the case as non-serious.
Age: 75.0
Sex: F
Vaccine: FLUA3, PPV
Symptoms: Injection site pain, Injection site rash
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 30-Mar-2018 by Seqirus from VAERS (VAERS ID: 727563), concerns a 75-year-old, elderly, female patient. The patient's concomitant medication included lovastatin for an unknown indication. On 30-Oct-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml (reported as unknown), route of administration: injection (reported as syr), anatomical location: right arm, batch number: 179303, expiry date: not reported) and non-company suspect product PNEUMOVAX (dose: unknown, route of administration: injection (reported as syr) anatomical location: left arm, batch  number: N022650 (as reported), expiry date: not reported). On the same day, after vaccination, the patient developed rash and pain on left arm (from the injection site to left elbow). The patient was advised with BENADRYL and to use ice on the site. On 01-Nov-2017, at 17:40 hrs, the patient reported to the pharmacist that rash was the same (not recovered) but pain reduced (recovering). The patient consulted primary care provider and was prescribed with MEDROL. The reporter assessed the case as non-serious.
Age: 84.0
Sex: F
Vaccine: FLUA3
Symptoms: Myalgia
Clinical narrative: This spontaneous case, reported by other health care professional to VAERS and initially retrieved on 30-Mar-2018 by Seqirus from VAERS (VAERS ID: 727610), concerns a 84-year-old, elderly, female patient. It was reported that the patient had no relevant medical history. The patient was allergic to DEMEROL, PERCOCET and sulfamethoxazole (since an unspecified date). The patient's concomitant medications included fluticasone, furosemide, amlodipine, lisinopril, levothyroxine, Potassium, isosorbide, clopidogrel, nabumetone, metoprolol and pravastatin for an unknown indication (since an unspecified date). On 27-Oct-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml (1 as reported), route of administration: intramuscular, anatomical location: right arm, batch number: 179402 and expiry date: not reported). On the same day, after vaccination, the patient was still complaining of muscle soreness in her arm. The lab tests were not reported. At the time of the report, the patient had not recovered from the event (myalgia). The reporter assessed the case as non-serious.
Age: 72.0
Sex: F
Vaccine: FLUA3
Symptoms: Blister, Herpes zoster, Pain, Rash
Clinical narrative: This is spontaneous case, reported by other non-health care professional to VAERS and initially retrieved on 30-Mar-2018 by Seqirus from VAERS (VAERS ID: 727624), concerns a 72-year-old elderly female patient. The patient's historical condition included migraine and allergic to penicillin, sulfa, clams. It was reported that, the patient was on various concomitant medications for an unknown indication. On 31-Oct-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml, route of administration: intramuscular, anatomical location: right arm, batch number: 179201). On 13-Nov-2017, 13 days after vaccination, the patient had developed shingles. The symptoms were reported as rash and blisters from the middle of back to the middle of front in the right side, additionally extreme pain. The patient consulted the primary care physician twice. At the time of this report, the patient had not yet recovered from the event. The reporter assessed the case as non-serious. Non-significant case correction received with IRD 30-Mar-2018: Case comment was changed.
Age: 69.0
Sex: M
Vaccine: FLUA3
Symptoms: Pruritus, Psoriasis, Urticaria
Clinical narrative: This is spontaneous case, reported by other non-health professional to VAERS and initially retrieved on 30-Mar-2018 by Seqirus from VAERS (VAERS ID: 727818), concerns a 69-year-old elderly male patient. The patient's historical conditions included reactive airways disease and regional enteritis (on unspecified dates). The patient was allergic to prednisone and AUGMENTIN. The patient's concomitant medications included CELEBREX, omeprazole, atenolol, NORVASC, triamterene, atorvastatin, milk thistle, aspirin, Vitamin D, ginkgo biloba and multivitamin for an unknown indication. On 30-Sep-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml (unk as reported), anatomical location: left arm, route of administration: intramuscular, batch number: not reported). On 07-Oct-2017, 7 days after vaccination (reported as within one week), the patient developed psoriatic lesions on the right side of the head and lesions eventually moved around to the left side of the head. Additionally, the patient developed urticaria on the torso region which had not resolved. The patient was seen by a physician assistant and suggested nothing to do as he could not take prednisone. The patient took triamcinolone acetonide for itching from primary care provider (PCP) on 20-Sep-2017. It was stated that, adjuvants in the vaccine were the reason for the event. It was reported that, the patient never had an adverse reaction to any other flu vaccine. At the time of this report, the patient had not yet recovered from the events. The reporter assessed the case as non-serious and causality as related to the suspect vaccine.
Age: 75.0
Sex: F
Vaccine: FLUA3, PNC13
Symptoms: Blood test, Electrocardiogram, Fatigue, Influenza like illness, Pain
Clinical narrative: This spontaneous case, reported by other health care professional to VAERS and initially retrieved on 30-Mar-2018 by Seqirus from VAERS (VAERS ID: 727829), concerns a 75-year-old elderly female patient. The patient's medical and medication history was not reported. On 05-Nov-2017, the patient received FLUAD (TIV) (dose: 1 as reported), route of administration: intramuscular, anatomical location: unknown, batch number: 179601 and expiry date: not reported). On the same day, the patient received PREVNAR 13 (dose: 1, route of administration: intramuscular, anatomical location: unknown, batch number: T08483 and expiry date: not reported). On 06-Nov-2017, the patient developed flu-like symptoms such as fever, body ache and tiredness. On 21-Nov-2017, blood test and electrocardiogram were performed but the results were not reported. The outcome of the events flu-like symptoms such as fever, body ache and tiredness were not recovered. The reporter assessed this case as non-serious. Non-significant case correction received with IRD on 30-Mar-2018: The co-suspect was added in the case comment. No changes were made in the narrative. Non-significant case correction received with IRD on 30-Mar-2018: Sentence formation in the case comment (co-suspect PREVNAR 13) was mentioned specifically. No changes were made in the narrative.
Age: 75.0
Sex: F
Vaccine: FLUA3, PNC13
Symptoms: Pyrexia
Clinical narrative: This spontaneous case, reported by other health care professional to VAERS and initially retrieved on 30-Mar-2018 by Seqirus from VAERS (VAERS ID: 727829), concerns a 75-year-old elderly female patient. The patient's medical and medication history was not reported. On 05-Nov-2017, the patient received FLUAD (TIV) (dose: 1 as reported), route of administration: intramuscular, anatomical location: unknown, batch number: 179601 and expiry date: not reported). On the same day, the patient received PREVNAR 13 (dose: 1, route of administration: intramuscular, anatomical location: unknown, batch number: T08483 and expiry date: not reported). On 06-Nov-2017, the patient developed flu-like symptoms such as fever, body ache and tiredness. On 21-Nov-2017, blood test and electrocardiogram were performed but the results were not reported. The outcome of the events flu-like symptoms such as fever, body ache and tiredness were not recovered. The reporter assessed this case as non-serious. Non-significant case correction received with IRD on 30-Mar-2018: The co-suspect was added in the case comment. No changes were made in the narrative. Non-significant case correction received with IRD on 30-Mar-2018: Sentence formation in the case comment (co-suspect PREVNAR 13) was mentioned specifically. No changes were made in the narrative.
Age: 65.0
Sex: F
Vaccine: FLUA3
Symptoms: Injection site bruising, Injection site swelling, Local reaction
Clinical narrative: This non-serious spontaneous case, initially received on 30-Mar-2018, reported by other health professional and concerns a 65-year-old elderly female patient. The patient was allergic to Bactrim, eggs, sulfa, penicillin and bovine. On 21-Nov-2017, the patient was administered with FLUAD (TIV) (dose: 0.5ml, route of administration: intramuscular, anatomical location: left deltoid, batch number 179003 and expiry date: not reported). On the same day, after few seconds of vaccination, the patient experienced local reaction and swelling at the site of injection, which looked like a bruise. After 10-15 minutes, patient was fine. At the time of this report, the outcome of the events was unknown. The reporter assessed this case as non-serious.
Age: 69.0
Sex: F
Vaccine: FLUA3
Symptoms: Discomfort, Loss of personal independence in daily activities, Musculoskeletal pain, Pain, Pain in extremity
Clinical narrative: This spontaneous case, reported by healthcare professional (other) to VAERS and initially retrieved on 30-Mar-2018 by Seqirus from VAERS (VAERS ID: 727892), concerns a 69-year-old, elderly, female patient. The patient's historical condition included arthritis (unspecified dates). The patient's current condition included diverticulitis (since an unspecified date). The patient's concomitant medication included AMBIEN for an unknown indication. On 16-Oct-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml (reported as 1), route of administration: injection (reported as SYR), anatomical location: left arm, batch number: unknown and expiry date: not reported). On the same day, after the vaccination, the patient experienced chronic achy pain, sometimes local and sometimes from top shoulder to elbow, which was sharp when moved in certain ways. It was reported that, the patient experienced difficulty to get comfortable on bed and in dressing. At the time of this report, the patient had not yet recovered from the events. The reporter assessed the events as non-serious.
Age: 74.0
Sex: F
Vaccine: FLUA3
Symptoms: Arthralgia, Asthenia, Myalgia, Pain in extremity
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 30-Mar-2018 by Seqirus from VAERS (VAERS ID: 727902), concerns a 74-year-old elderly female patient. The patient's medical history and concomitant medications were not reported. On 14-Nov-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml (1 as reported), route of administration: intramuscular, anatomical location: left arm, batch number: 178323). On 15-Nov-2017, 1 day after vaccination, the patient complained of pain in arm mostly at night. Additionally, muscle and joint pain, the patient also had loss of strength and energy for three and half weeks. At the time of this report, the patient had recovered from all the events except pain in extremity. The reporter assessed the case as non-serious.
Sex: F
Vaccine: FLUA3
Symptoms: Pain in extremity
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 30-Mar-2018 by Seqirus from VAERS (VAERS ID: 727941), concerns 76-year-old elderly male patient. The patient's historical drug included LIPITOR and allergic to latex, Neosporin and sulfa. The patient's concomitant medications included JANTOVEN, Carbidopa-levodopa b. On 17-Oct-2017, the patient was administered with FLUAD (TIV) (dose: 0.5ml (1 as reported), route of administration: intramuscular, anatomical location: right arm, batch number: 179403). On 20-Oct-2017, 3 days later, the experienced pain in arm which persisted (reported as started hurting and it still hurts). The outcome of all the events was not recovered. The reporter assessed the case as non-serious.
Age: 67.0
Sex: F
Vaccine: FLUA3, PNC13
Symptoms: Erythema, Induration, Injection site rash, Pain, Rash
Clinical narrative: This spontaneous case, reported by healthcare professional (other) to VAERS and initially retrieved on 30-Mar-2018 by Seqirus from VAERS (VAERS ID: 728016), concerns a 67-year-old, elderly, female patient. The patient's historical conditions, allergies, current illness were not reported. However, patient's concomitant medication included carvedilol, CRESTOR, furosemide, Losartan and spironolactone for an unknown indication. On 13-Nov-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml (reported as 1), route of administration: intramuscular, anatomical location: left arm, batch number: 179401 and expiry date: not reported) and non-company suspect product PREVNAR 13 (dose: 1 DF (reported as 1), route of administration: intramuscular, anatomical location: left arm, batch number: S89081 and expiry date: not reported). On 15-Nov-2017, after 2 days of vaccination, the patient presented with approximately 3 and 1/2 inches redness, raised rash, soreness, which were hard, hot to touch and increased in size, but slowed down (as reported). It was reported that, rash covered the both injection sites. At the time of this report, the outcome of the events was unknown. The reporter assessed the events as non-serious.
Age: 67.0
Sex: F
Vaccine: FLUA3, PNC13
Symptoms: Skin warm
Clinical narrative: This spontaneous case, reported by healthcare professional (other) to VAERS and initially retrieved on 30-Mar-2018 by Seqirus from VAERS (VAERS ID: 728016), concerns a 67-year-old, elderly, female patient. The patient's historical conditions, allergies, current illness were not reported. However, patient's concomitant medication included carvedilol, CRESTOR, furosemide, Losartan and spironolactone for an unknown indication. On 13-Nov-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml (reported as 1), route of administration: intramuscular, anatomical location: left arm, batch number: 179401 and expiry date: not reported) and non-company suspect product PREVNAR 13 (dose: 1 DF (reported as 1), route of administration: intramuscular, anatomical location: left arm, batch number: S89081 and expiry date: not reported). On 15-Nov-2017, after 2 days of vaccination, the patient presented with approximately 3 and 1/2 inches redness, raised rash, soreness, which were hard, hot to touch and increased in size, but slowed down (as reported). It was reported that, rash covered the both injection sites. At the time of this report, the outcome of the events was unknown. The reporter assessed the events as non-serious.
Sex: F
Vaccine: FLUA3, PPV
Symptoms: Erythema, Malaise, Peripheral swelling
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 30-Mar-2018 by Seqirus from VAERS (VAERS ID: 728038), concerns a 69-year-old, elderly female patient. The patient's historical procedure included mastectomy. The patient's current condition included high blood pressure and had no other current illness. The concomitant medications included, losartan with hydrochloride, spironolactone and terazosin. On 21-Nov-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml, route of administration: intramuscular, anatomical location: right arm, batch number: 178601, expiry date: not reported) and PNEUMOVAX (dose: 1 (as reported), route of administration: intramuscular, anatomical location: right arm, batch number: N020502 (as reported), expiry date: not reported). On 22-Nov-2017, the next day of vaccination, the patient developed red and swollen arm. The patient also experienced malaise. The patient wanted both shots in one arm as mastectomy was done on other side. The outcome of the events was unknown. The reporter assessed the case as non-serious.
Age: 81.0
Sex: M
Vaccine: FLUA3
Symptoms: Dizziness, Fall
Clinical narrative: This spontaneous case, reported by other health care professional to VAERS and initially retrieved on 30-Mar-2018 by Seqirus from VAERS (VAERS ID: 728039), concerns a 81-year-old, elderly, male patient. The patient's medical history and the concomitant medications was unknown. On 20-Nov-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number: 179523 and expiry date: not reported). On the same day, after immunization, the patient fell down during the checkout process at the store. The other person (cashier as reported) thought that, the patient was a little dizzy before it happened. The patient refused to call emergency medical services (911 as reported). At the time of the report, the patient had recovered from the event. The reporter assessed the case as non-serious.
Age: 71.0
Sex: M
Vaccine: FLUA3
Symptoms: Insomnia, Mobility decreased, Pain in extremity
Clinical narrative: This spontaneous case, reported by other health care professional to VAERS and initially retrieved on 30-Mar-2018 by Seqirus from VAERS (VAERS ID: 728049), concerns a 71-year-old elderly male patient. The patient had no known allergies. The patient's current illness included diabetes. The concomitant medications were not known. On 18-Nov-2017, the patient received FLUAD (TIV) (dose: 1 as reported), route of administration: intramuscular, anatomical location: right arm, batch number: 179302 and expiry date: not reported). On the same day, the patient developed pain in the arm and later he had trouble in moving his arm. It was reported that the patient could not sleep on his side. No laboratory tests were performed. The outcome of the events insomnia, mobility decreased and pain in extremity was not recovered. The reporter assessed this case as non-serious..
Age: 66.0
Sex: M
Vaccine: FLUA3, PPV
Symptoms: Injection site erythema
Clinical narrative: This non-serious spontaneous case, initially received on 30-Mar-2018, reported by other health professional and concerns a 66-year-old elderly female patient. On 06-Nov-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number and expiry date: not reported) and was also administered with PNEUMOVAX (dose: unknown, route of administration: intramuscular, anatomical location: right arm, batch number and expiry date not reported). On 07-Nov-2017, after 1 day of vaccination, the patient experienced redness along the right biceps. It was reported that, the patient did some lifting at work and it was not the cause for the event. On an unspecified date, the patient had no redness, swelling or any other reactions near injection site. The reporter assessed this case as non-serious.
Sex: F
Vaccine: FLUA3, PPV
Symptoms: Erythema, Pain, Swelling, Vaccination site infection
Clinical narrative: This non-serious spontaneous case, initially received on 30-Mar-2018, reported by other health professional and concerns a 74-year-old elderly female patient. The patient was allergic penicillin. The patient's concomitant medications included Metformin, TRAMADOL, Atorvastatin and BACLOFEN. On 21-Nov-2017, the patient was administered with FLUAD (dose: 0.5ml, route of administration: intramuscular, anatomical location: right arm, batch number: 179523 and expiry date: not reported) and was also administered with PNEUMOVAX (dose: 1 DF, route of administration: intramuscular, anatomical location: right arm, batch number: N024384 and expiry date: not reported). On 22-Nov-2017, 1 day after vaccination, the patient experienced pain, redness, swelling and area of vaccination was infected. The patient was taken to the hospital and was treated with antibiotics. At the time of this report, the outcome of the events was unknown. The reporter assessed this case as non-serious.
Age: 94.0
Sex: F
Vaccine: FLUA3
Symptoms: Hypoaesthesia, Sensory disturbance
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 30-Mar-2018 by Seqirus from VAERS (VAERS ID: 728232), concerns a 94-year-old, elderly, female patient. The patient's medical history was not reported and had no known allergies. The patient's concomitant medications included, alprazolam, isosorbide, spironolactone, carvedilol, furosemide, JANTOVEN, tramadol for unknown indications. On 20-Nov-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml, route administration: intramuscular, anatomical location: right arm, batch number: 178623, expiry date: not reported). On the same day, after vaccination the patient developed numbness in left leg after waking up from a short nap. The patient described that, the sensation was unusual, and it continued throughout 24-Nov-2017 (on which the event was reported to pharmacy). The patient was unable to consult primary care provider. At the time of the report, the patient had not recovered from the event. The reporter assessed the case as non-serious.